A look back at the week's news.
COVID-19 vaccination during pregnancy may reduce infants’ risk of infection during the early months of life, according to a recent study.
A prospective study published in the International Scientific Research Journal has found that colposcopy was able to detect exoservicitis in about one-third of women with uterine fibroids.
Uterine cancer is currently the only cancer type not covered by the World Trade Center (WTC) Health Program.
A research letter published in JAMA Network Open has found no difference in clinical outcomes for in vitro fertilization (IVF) via intracytoplasmic sperm injection (ICSI) between COVID-19 vaccinated and unvaccinated women of reproductive age.
Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.
Currently approved for the treatment of vulvovaginal candidiasis (VVC), and if the sNDA is approved, ibrexafungerp (Brexafemme; Scynexis) would be the first and only oral non-azole medication for the prevention of recurrent VVC.